Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
High-throughput analysis of the transcriptome and proteome individually are used to interrogate complex oncogenic processes in cancer.However, an outstanding challenge is how to Beaded Headstall combine these complementary, yet partially disparate data sources to accurately identify tumor-specific gene products and clinical biomarkers.Here, we intr